Research News and Research

RSS

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

29 Nov 2004

British parents admit responsibility lies with them to tackle childhood obesity

More than 80% of parents say that they intend to be more accountable for their child's weight and four in five believe that measures set out in the Government's White Paper last week would go a long way to help them combat obesity in their children.

29 Nov 2004

Effective management of insomnia begins with recognition and adequate assessment

A seminar in this week’s issue of THE LANCET outlines the common but poorly understood condition of insomnia, concluding that awareness and assessment of insomnia by family doctors is a priority.

29 Nov 2004

Study finds that stomach cancer originates from bone marrow derived stem cells, rather than from stomach stem cells

A common assumption among cancer specialists is that most cancers originate from tissue stem cells – for example, the gastric stem cells contained in the lining of the stomach.

29 Nov 2004

New research may lead to treatments for atherosclerosis

Scientists are one step closer to deciphering the molecular signaling process controlling innate immunity with the discovery that a molecule called IRAK1 regulates the expression of the anti-inflammatory cytokine IL-10. Because atherosclerosis patients often have elevated IL-10 levels, IRAK1 may be a viable target for developing therapeutics for atherosclerosis.

29 Nov 2004

New computer-aided diagnosis (CAD) methods for cancer

Not all masses are cancer. When a person undergoes a scan to identify a lump or nodule, the radiologist looks at the texture, the borders and the shape to determine if it is malignant or just a benign growth.

29 Nov 2004

Cancer survival rates differ among ethnic groups in New Zealand

There were 115,811 adult patients with an invasive cancer recorded on the New Zealand Cancer Registry between 1994 and 2002. The study linked these patients to the Mortality Collection in order to calculate survival rates. Ethnicity (Maori, Pacific, and non-Maori/non-Pacific) was assigned from hospitalisation and health administration databases.

24 Nov 2004

U.S. pharmacists not opposed to importing drugs to lower patients' costs

Many community pharmacists are not opposed to importing drugs to lower patients' costs as long as those drugs are channeled through U.S. pharmacies to ensure safety and efficacy, according to a study by pharmacists at the University of Illinois at Chicago and the University of Michigan.

24 Nov 2004

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.

24 Nov 2004

Study highlights importance of pesticide worker dermal exposure

Agricultural pesticide workers are not only exposed to pesticides from inhalation, but also through their skin. The dermal route of exposure to chlorpyrifos, a common agricultural pesticide, is known to contribute substantially to workers’ total exposure

24 Nov 2004

Cord blood registry sees FDA regulation as good for consumers and industry

Beginning in May 2005, cord blood banks must meet new federal safety standards mandated by the Food and Drug Administration (FDA).

24 Nov 2004

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.

24 Nov 2004

Parents are not happy about television food advertising directed at their children

Responses from parents of school aged children found that while parents were sceptical about claims made by food advertising, they considered it to exert a strong influence on their children.

24 Nov 2004

New research into nicotine addiction

The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.

24 Nov 2004

Scientists have given blind nerve cells the ability to detect light

Scientists at the University of California, Berkeley, have given "blind" nerve cells the ability to detect light, paving the way for an innovative therapy that could restore sight to those who have lost it through disease.

24 Nov 2004

Weight gain beginning in childhood can lead to an enlarged heart

Weight gain beginning in childhood can lead to an enlarged heart by early adulthood, researchers reported in Circulation: Journal of the American Heart Association.

24 Nov 2004

Study links a novel protein pathway to the aggressive progression of breast cancer

Cytogen Corporation today announced the publication of a study linking a novel protein pathway to the aggressive progression of breast cancer.

24 Nov 2004

Research looks at the relationship between fetal health during pregnancy and later development of the brain

A new Canada Research Chair (CRC) at The University of Western Ontario is studying the relationship between fetal health during pregnancy and later development of the brain.

24 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

More muscle facilitates the ability to regulate blood pressure

People with more muscle than fat have increased ability to regulate their blood pressure in response to stress, according to a Medical College of Georgia study.

24 Nov 2004

Research News and Research

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

British parents admit responsibility lies with them to tackle childhood obesity

Effective management of insomnia begins with recognition and adequate assessment

Study finds that stomach cancer originates from bone marrow derived stem cells, rather than from stomach stem cells

New research may lead to treatments for atherosclerosis

New computer-aided diagnosis (CAD) methods for cancer

Cancer survival rates differ among ethnic groups in New Zealand

U.S. pharmacists not opposed to importing drugs to lower patients' costs

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

Study highlights importance of pesticide worker dermal exposure

Cord blood registry sees FDA regulation as good for consumers and industry

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Parents are not happy about television food advertising directed at their children

New research into nicotine addiction

Scientists have given blind nerve cells the ability to detect light

Weight gain beginning in childhood can lead to an enlarged heart

Study links a novel protein pathway to the aggressive progression of breast cancer

Research looks at the relationship between fetal health during pregnancy and later development of the brain

FDA approval of Tysabri, for the treatment of multiple sclerosis

More muscle facilitates the ability to regulate blood pressure

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®